Bank of Montreal’s Altimmune ALT Stock Holding History

Bank of Montreal’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,000	Closed	-$40K	–	4749
2020 Q2	$40K	Hold	2,000	–	–	﹤0.01%	3527
2020 Q1	$6K	Buy	+2,000	New	+$4.6K	﹤0.01%	3625

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's ALT Position: Q2 2024 in Review

Bank of Montreal sold out of Altimmune (ALT) in Q2 2024, closing a stake of 20,965 shares — an estimated $187K sold.

Bank of Montreal first reported a position in ALT in Q1 2016 and held it in 9 quarters. The position peaked at $283K in Q2 2020. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

Bank of Montreal reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
Bank of Montreal sold 20,965 Altimmune shares in Q2 2024, an estimated $187K.
Bank of Montreal first reported a position in Altimmune in Q1 2016 and held it in 9 quarters.
Bank of Montreal's Altimmune position peaked at $283K in Q2 2020.
173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.